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Introduction
Shared decision making (SDM) is a process of exchanging 
information and preferences concerning an intervention, 
aimed at reaching an agreed, decision (Charles, Gafni, & 
Whealan, 1999; Edwards & Elwyn, 2009; O’Connor, 
2005).
It was developed in mental health as a response to the 
well-documented difficulties in ensuring concordance about 
psychiatric medication and the existing doubts about the effi-
cacy of psychiatric medication (Morrison, Hutton, Shiers, & 
Turkington, 2012; Nose, Barbui, & Tansella, 2003). Given 
the dominance of medication as an intervention in the mental 
health field, the pilot project described below focused on 
SDM in psychiatric medication management.
SDM is recognised as a promising strategy for enhanc-
ing collaboration between clinicians and service users, due 
to complementary knowledge brought to the SDM process 
(Morant, Kaminskiy, & Ramon, 2015). Participation in 
treatment decision-making is desired by many service users 
(Joosten et al., 2008), is feasible even during an acute 
admission (Hamman et al., 2006), improves service users’ 
satisfaction (Loh, Simon, & Wills, 2007), self-efficacy and 
self-confidence, likely to empower and to reduce the use of 
coercion (Stovell, Morrison, Panyiotou, & Hutton, 2016). It 
is also a core component of person-centred care (Ahmed, 
Ellins, Krelle, & Lawrie, 2014; Davidson, Tondora, Pavlo, 
& Stanhope, 2017) and of co-production between service 
users and providers (Clark, 2015; Coalition for Collaborative 
Care: Action for Long-Term Condition, 2017).
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Background: Shared decision making (SDM) is recognised as a promising strategy to enhance good collaboration 
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conducting a larger study and exploring application for non-medical decisions.
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At present, there is only a small number of known ran-
domised controlled trial (RCT) studies on mental health 
SDM (Hamann et al., 2011; Loh et al., 2007; Stovell et al., 
2016), but there is a growth in researching attitudes to it of 
service providers and users (Eliacin, Salyers, Kukla, & 
Matthias, 2015; Puchner et al., 2016) of different age 
groups (O’Neal et al., 2008; Simmons, Hetrick & Jorm 
2010) and in developing decision-making aids (Deegan, 
2010).
Previous interventions on SDM in psychiatric medica-
tion management targeted either prescribers (Priebe et al., 
2007) or service users (Deegan, Rapp, Holter, & Riefer, 
2008). Yet as change may best be achieved by simultane-
ously targeting all those involved in this process this pro-
ject aimed to develop and evaluate the feasibility, 
acceptability and impact of training for service users, psy-
chiatrists and care co-ordinators (who may come from 
nursing, occupational therapy or social work) to encourage 
SDM in the prescription and management of psychiatric 
medication, focusing on people with long-term mental ill 
health (see Figure 1).
Specific objectives were as follows:
1. Develop a training programme designed to pro-
mote SDM processes in psychiatric medication 
management, based on existing literature and con-
sultations with relevant stakeholders.
2. Deliver this training separately to groups of service 
users, psychiatrists and care co-ordinators in adult 
community psychiatric settings.
3. Investigate the impact of the training on enhancing 
the application of SDM at medication reviews by 
applying a mixed-method process and outcome 
(detailed below).
Methods
Setting
The project was guided by participatory principles (Reason 
& Bradbury, 2008), and conducted in community services 
for adults with long-term mental health problems of an 
East of England National Health Services (NHS) Trust. 
Ethical approval was obtained from the local NHS 
Research Ethics Committee.
Intervention design
A scoping search of internationally published, grey litera-
ture, and Internet material on SDM was conducted. Local 
stakeholder consultation took place via focus groups with 
service users, psychiatrists, and care co-ordinators (total 
N = 53). Discussions centred on current decision-making 
practices in psychiatric medication, preferences for how 
this could be improved, perceived facilitators and barriers 
Figure 1. Format and content of ShiMME training programmes.
*The care co-ordinators’ group included nurses, occupational therapists, psychologists, support workers, peer workers and other practitioners.
# Training groups in each location were amalgamated for support groups.
Service users Psychiatrists Care co-ordinators*
Participants Total 47 Total 12 Total 35
Facilitators Service user and psychiatrist Service user and 
psychiatrist
Service user and psychiatric 
nurse
Number and 
duration of sessions
4 sessions of 2 hours at fortnightly 
intervals
2 sessions of 2 hours one 
month apart
3 sessions of 1.5 hours at 
monthly intervals
Follow-up offered •• Follow-up session one month 
later.
•• Additional bi-monthly support 
groups offered
Whole-team follow-up sessions offered at 2 -3 monthly 
intervals for up to 12 months.
Core content •• The concept and process of shared decision-making.
•• Facilitators of and barriers to shared decision-making.
•• Accessing and evaluating information about medication.
•• Alternatives to medication.
•• Issues around coming off medication.
•• The ShiMME website and three shared decision-making forms.
Additional content 
for specific groups
•• Well-being and assertiveness.
•• IT sessions (in computer suite).
•• Input from Trust pharmacist.
Critical issues in
managing psychiatric
medicine in collaboration
with service users.
Adopting the role of a 
shared decision-making 
coach.
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and suggestions for the content and format of the training 
intervention. (see Kaminskiy, Ramon & Morant, 2013; 
Stead, Morant, & Ramon, 2017).
A working group with service users trainers (i.e. peo-
ple who use mental health services, trained to offer train-
ing to providers and service users), practitioners and 
researchers developed the training programme format, 
content, materials, and decision aids. This included 
designing a web-site containing training support materi-
als, links to other relevant resources, four videos of medi-
cation-related consultations played by trained actors and 
forms to support and record SDM processes (preferences, 
priorities and feedback).
Intervention format, content and 
delivery
Training was delivered to separate groups of service users, 
psychiatrists and care co-ordinators, providing a safe envi-
ronment for open discussion among peers and addressing 
their specific training needs, by a professional and a ser-
vice user trainer. Group sizes ranged from 2 to 12; a vari-
ety of group-based and participatory learning techniques 
were employed. The core content was the same for all 
groups, and focused on the process of SDM. Stakeholders’ 
groups-specific variations are shown in Figure 1; the most 
important of which is the focus on assertiveness in the 
training for service users. Training sessions were delivered 
at fortnightly or monthly intervals to allow individual self-
study using web-site materials, opportunities to implement 
new skills in practice, and access to additional user-trainer 
support for service users. Training groups were held 
throughout 2013 in the Trust’s and University locations.
Participants and recruitment
Service user inclusion criteria were as follows: being in the 
care of Rehabilitation and Recovery services for at least 
6 months; having one or more of the diagnoses of schizo-
phrenia, bi-polar disorder and depression, taking any psy-
chiatric medication (antipsychotics, mood stabilisers, 
anti-depressants or anxiolytics) currently and for at least 
6 months previously, selected for participation by a mem-
ber of their clinical team, having capacity to consent, able 
to speak and understand English without an interpreter, 
and aged 18–65.
Suitable potential participants were sent an initial invi-
tation letter by members of their clinical team, who were 
available for preliminary discussions. Interested service 
users were then provided with more information by 
researchers. Training was offered to all psychiatrists and 
care coordinators who prescribe, monitor or discuss medi-
cation with this group of service users.
Data collection
As the study aimed to design and evaluate a novel interven-
tion, a randomised design was considered premature for this 
early stage of development (Craig, Dieppe, & Macintyre, 
2008). The intervention was evaluated within a multi-
method process and outcome-oriented approach within a 
before and after, uncontrolled design (see Figure 2). This 
Figure 2. Study Design.
766 International Journal of Social Psychiatry 63(8)
assessed the impact of the training on medication decision-
making; feasibility, acceptability and participant experi-
ences of the training programme; and cost effectiveness. At 
the end of the training programme, participants were asked 
to anonymously evaluate the value of the training for them. 
As the training lasted for a short duration, an evaluation of 
the outcomes at that stage was premature.
1. Quantitative measures.
In line with recommendations for evaluating SDM (Joosten 
et al., 2008), multiple relevant outcomes were assessed. 
Measures were completed at pre-training baseline and 
again at the 12 months follow-up point.
Service users completed the following measures:
1. The 16 items Decision Conflict Scale (DCS, 
O’Connor, 2005) measure of service users’ views 
their medication decisions, with 5 related subscales 
assessing: access to information, values clarity, 
feelings of support, certainty in decision and 
whether the decision is likely to be implemented. 
This tool is well validated, sensitive to changes fol-
lowing decision support interventions (O’Connor 
et al., 2009), and applicable in mental health set-
tings (Bunn & O’Connor, 1996).
2. The 12-item ‘Scale to assess therapeutic relation-
ships in community mental health care’ (STAR) 
(McGuire-Snieckus, McCabe, Catty, Hansson, & 
Pribe, 2007). Participating psychiatrists and care 
co-ordinators completed the STAR clinicians’ ver-
sion in relation to two service users whose medica-
tion management they regarded as ‘problematic’ 
and ‘very satisfactory’ at baseline and at 12 months 
follow-up. For the statistical tests applied, see 
introduction to the data analysis section.
3. The 12-item OPTION scale (Elwyn, Edwards, & 
Wensing, 2003) was adapted to assess service 
users’ self-report of whether clinicians’ interactive 
styles promoted SDM.
4. Two ratings of decision-making in preferred and 
current medication management practice were 
obtained using the single item Control Preferences 
Scale (CPS; Degner et al., 1997), asking respond-
ents to endorse 1 of 5 statements ranging from 
decision-making entirely by the doctor to decision-
making entirely by the service user.
5. Attitudes to taking medication were assessed using 
the Drug Attitude Inventory (DAI short version; 
Hogan, Awad, & Eastwood, 1983).
2. Qualitative measures.
Training intervention feasibility, acceptability and participant 
experiences. Participants’ anonymous written feedback on 
the training programme via fixed-format, and open ques-
tions were completed after each session, and immediately 
after programme completion. These asked what partici-
pants hoped to learn from the programme, views on its 
content, impact, practical aspects, teaching methods and 
support materials.
To gain greater understanding of participants’ experi-
ences and the perceived impacts of the training pro-
gramme, we also conducted semi-structured interviews 
with sub-samples of service users (n = 12), psychiatrists 
(n = 6) and care co-ordinators (n = 11) at 12 months fol-
low-up. Service users were interviewed by service users 
trained in interviewing, while professionals were inter-
viewed by academic researchers. Questions focused on 
professional-client discussions about medication follow-
ing the intervention, changes to medication and impacts 
on well-being, evaluation of the intervention and sugges-
tions for improvements.
3. Cost effectiveness.
Socio-demographics and service use information were 
obtained at baseline and 12 month follow-up using 
the Client Sociodemographic Service Receipt Inventory 
(CSSRI) (Chisholm et al., 1999), analysed by an experi-
enced health economists team, alongside unit cost 
information.
Data analysis 
Quantitative outcome data were analysed using paired t 
tests or non-parametric within-subject tests where appro-
priate, to compare pre-training and follow-up scores (DCS, 
OPTION, STAR, and DAI measures). CPS data were ana-
lysed using Pearson’s exact chi squared test. For all tests, p 
values of < 0.05 were considered significant. Written feed-
back data were collated for descriptive analysis. Qualitative 
data from semi- structured interviews were transcribed 
verbatim, and analysed using thematic analysis (Braun & 
Clark, 2006). To assess health economic impacts, total 
costs of the intervention per person were estimated. Service 
use costs (health/social services and medication) in the 
year before and following the intervention were obtained 
by combining CSSRI data with unit cost information 
(Curtis, 2009).
Results
Participant characteristics
In all, 47 service users, 35 care co-ordinators and 12 psy-
chiatrists participated in our training programme. 
Attendance, demographic, clinical and professional charac-
teristics of service user and practitioner participants are 
shown in Tables 1 and 2. Attendance at training sessions 
was generally high across all groups. Service users had a 
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high level of formal education, very few were in work; the 
majority were in receipt of state benefits, had long histories 
of service contact (17.2 years on average) and were high 
users of medication (5 medications on average, of which 3 
were for mental health problems). Twenty service users 
(43%) took mood stabilisers, 21 (45%) took antidepres-
sants and 32 (68%) were on antipsychotic medication.
Nine of the psychiatrist participants were consultants. 
Community psychiatric nurses and occupational therapists 
were the most common professional groups among care co-
ordinator participants, with a few non-medical and non-pro-
fessional groups also represented (clinical psychologists, 
social workers, support workers and peer support workers).
Impact of the training: quantitative measures
Pre-training quantitative data were provided by 100% of 
participants. At 12-month follow-up data were obtained 
from 33 service users (70%), 11 care co-ordinators (31%) 
and 6 psychiatrists (50%). Sensitivity analyses conducted 
on the main measures did not suggest biases due to miss-
ing data at follow-up (see findings in Table 3).
Service users. Changes between pre-training and 12-month 
follow-up scores for service users on the DCS total score 
and sub-scales indicated decrease of decisional conflict. 
These changes reached statistical significance for the sub-
scales for feeling informed (p = 0.002) and clarity of values 
(p = 0.001). Changes on the total score (p = 0.014) and 2 of 
the other 3 sub-scales on this measure approached statisti-
cal significance (feeling supported p = 0.063, and feeling 
an effective decision has been made p = 0.061). There was 
also a statistically significant change on the OPTION scale 
(p = 0.021), representing an increase in practitioners’ inter-
actional style in promoting SDM as perceived by service 
users. Scores on the DAI did not show significant changes, 
Table 1. Demographic characteristics and attendance of the service user group (N = 47).
Gender Employment*
•• Female n = 22 (47%) •• Paid/self-employed n = 3 (6%)
•• Male n = 25 (53%) •• Voluntary employment n = 7 (14%)
 •• Unemployed n = 25 (50%)
 •• Student (inc part time) n = 4 (8%)
 •• Age related retirement n = 4 (8%)
Mean age 48.0 years  
Ethnicity In receipt of state benefits:* n = 43 (92%)
•• White n = 42 (89%) •• Disability living allowance n = 39 (83%)
•• Black n = 1 (2%) •• Employment support allowance n = 9 (19%)
•• Asian n = 0 •• Income support n = 20 (43%)
•• Other n = 3 (6%) •• Housing benefit n = 19 (40%)
•• No data n = 1 (2%) •• Other n = 6 (13%)
Marital status Diagnoses*
•• Single/unmarried n = 26 (55%) •• Schizophrenia/ schizo-affective/ 
psychosis
n = 28 (60%)
•• Married n = 10 (21%) •• Depression n = 12 (26%)
•• Separated n = 1 (2%) •• Bipolar affective disorder n = 9 (19%)
•• Divorced n = 9 (19%) •• Anxiety n = 4 (9%)
•• No data n = 1 (2%) •• Personality disorder n = 5 (11%)
 •• PTSD n = 4 (9%)
 •• Other n = 9 (19%)
Education Length of contact with mental 
health services
Mean 
17.2 years•• Tertiary/further n = 30 (64%)
•• Secondary n = 14 (30%)
•• Primary or less n = 1 (2%)
•• No data n = 2 (4%)
Number of sessions offered 
in training intervention
4 x 2 hours Attendance 37 of 47 (79%) 
attended at 
least 3 sessionsNumber of cohorts training 
delivered to
6
Source: Stead et al. 2017 (Psychiatric Bulletin).
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remaining constant at a neutral to positive position on 
average between baseline and follow-up (p = 0.321). Ser-
vice users’ ratings of the quality of their therapeutic rela-
tionships were in the neutral to positive range, but 
significantly lower for their psychiatrist than for the other 
mental health practitioner involved at both baseline and 
follow-up (p < 0.001). Ratings of both these relationships 
showed no changes between baseline and follow-up in 
both total scores and sub-scales.
On the single item CPS ratings of medication decision-
making with psychiatrists, the modal preferred style was 
consistently ‘the doctor and I make the decision together’ 
(indicated by 69% of the respondents at baseline and 56% at 
follow-up). No respondents indicated a preferred style which 
did not involve them in decision-making to some extent.
Ratings of how medication decisions are usually made 
showed that both at baseline and follow-up the majority of 
responses were split between ‘the doctor and I make the 
decision together’ and ‘the doctor makes the decision after 
seriously considering my opinion’ (66% of the respondents 
at baseline and 78% at follow-up gave one of these 
responses). At baseline, 10 service users (31%) selected ‘the 
doctor makes the decision’ to describe usual medication 
decision-making, compared to only 3 (9%) at follow-up.
Practitioners. As numbers at the follow-up were small, 
analysis was conducted on both practitioner groups 
together. This provided a baseline sample of 47 and a fol-
low-up sample of 17. Analysis carried out on each group 
separately produced very similar results to those of the 
combined sample. At both baseline and follow-up, practi-
tioners rated their relationship with a service user whose 
medication management was ‘very satisfactory’ as signifi-
cantly better than for someone for whom this was ‘prob-
lematic’ (p = 0.002 at baseline, p < 0.000 at follow-up). No 
significant changes in these ratings were found between 
baseline and follow-up.
Service use and costs
Service use information shows decreases in hospitalisation 
and increases in community activities for all but two ser-
vice users at follow-up. For 39.7% of service users reduced 
decisional conflict following the intervention was 
Table 2. Demographic characteristics and attendance of clinicians.
Care coordinators (n = 35) Psychiatrists (n = 12)
Gender
•• Female n = 27 (77%) n = 6 (50%)
•• Male n = 8 (23%) n = 6 (50%)
Mean age 45.0 years 46.4 years (n = 4 no data)
Ethnicity
•• White n = 31 (89%) n = 6 (50%)
•• Black n = 1 (3%) n = 0 (0%)
•• Asian n = 1 (3%) n = 3 (25%)
•• Other n = 1 (3%) n = 1 (8%)
•• No data n = 1 (3%) n = 2 (17%)
Job title Grade
•• CPN/Nurse n = 11 (31%) •• Consultant n = 9 (75%)
•• Occupational therapist n = 9 (26%) •• Speciality doctor n = 1 (8%)
•• Clinical psychologist n = 2 (6%) •• Trainee n = 2 (17%)
•• Social worker n = 2 (6%)  
•• Support time and recovery worker n = 6 (17%)  
•• Peer support worker n = 2 (6%)  
•• Team leader/deputy manager n = 3 (9%)  
Mean duration in current post: 5.9 years (n = 1 no data) 4.5 years (n = 1 no data)
Mean duration in current team: 5.5 years (n = 1 no data) 3.2 years (n = 2 no data)
Number of sessions in training 
intervention offered:
3 x 1.5 hours 2 x 2 hours
Number of cohorts training delivered to: 2 + 1 (team training) 2 + 1 (team training)
Attendance: 20 of 21 (95%) attended at 
least 2 sessions;
6 of 10 (60%) attended both training 
session;
14 attended team training day 2 attended team training day
Source: Stead et al. 2017 (Psychiatric Bulletin).
*a person may have more than one diagnoses attributed to them.
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associated with lower service use costs, while for 57.5% 
this was associated with slightly increased costs. Long 
periods of hospitalisation for 2 individuals contributed 
substantially to increased costs. These findings indicate 
the potential of lowering costs in a larger sample.
Experiences of the training: feedback 
questionnaires
Immediate post programme feedback data were obtained 
from 33 (70%) service users, 22 (63%) care coordinators 
and 6 (50%) psychiatrists. The training programme mostly 
met respondents’ expectations, and high levels of satisfac-
tion with its content and pitch of teaching were reported by 
the majority of service users and care coordinators. 
Comments included ‘I feel more able to influence my treat-
ment rather than taking a passive role’ (service user); 
‘Overall I found it very informative and I feel it’s given me 
more confidence in this area’ (care-coordinator).
Psychiatrists’ evaluations of the content and level of 
teaching were more mixed:
Well, it would be good to set realistic expectations, because 
some people, especially people with schizophrenia they 
sometimes have a lack of insight… so on one hand it may 
make their relationship much closer and better on the other 
hand that might also lead to some confrontation about … now 
I have read a few side effects about the medication I want to 
stop my medication. (PSY06)
the approach to the topic occasionally felt stereotypical 
towards psychiatrists and how they liaise with patients. 
Psychiatrists were portrayed in a negative light; at some 
points the approach underestimated psychiatrists’ knowledge 
or interest in collaborative work. (PSY01)
All stakeholder groups particularly valued opportunities 
for discussion, exchange of ideas and experiences with 
peers. Practitioners appreciated suggestions for informa-
tion and SDM support tools. Use of the project website 
was variable, with most psychiatrists, about half of service 
users, but less than a third of care coordinators having 
accessed the website.
Both groups of practitioners considered the programme 
relevant to their clinical practice, but were less certain that 
it would shape their future practice. Service users too were 
cautious about the future impact of the programme on 
practice (see further discussion in Stead et al. (2017).
Experienced impact of the training:  
semi-structured interviews at 12-month  
follow-up
Interviews with service users reflected the generally posi-
tive views seen in post-training feedback. High levels of 
satisfaction were explained in terms of feeling empow-
ered, increased understanding of their experiences by prac-
titioners, and an improved sense of wellbeing. They valued 
also the group-based nature of the training that enabled 
peer support and social connections. Areas earmarked for 
improvement in the training programme were information 
technology (IT) arrangements, request for more sessions 
and managing group dynamics:
It definitely makes me ask questions about what’s being 
offered, you know, wanting to be really clear what the side 
effects are as well as the helpfulness of the drug. I think to 
speak up and not be so kind of placid always and just accepting 
what people say, but questioning what it is that I am being 
offered. Yeah, I think I feel more confident about going to see 
the psychiatrist than I did initially, yeah. (Service user)
Interviewed care co-ordinators’ and psychiatrists’ views at 
the immediate post-programme feedback were similar to 
their views at 12-month follow-up. Care co-ordinators val-
ued the training more than psychiatrists, citing the value of 
time and space to reflect on SDM, the usefulness of the 
informal yet challenging approach to training, and the 
opportunity to develop their practice:
Table 3. Primary service user outcomes: DCS, OPTION and DAI measures.
(N) Pre-SHiMME 
training
12-month 
follow up
Mean 
diff.
95% conf. 
interval
T (df) p-value  
(1 tailed)
Mean (SD) Mean (SD)
DCS Total (32) 41.2 (22.2) 31.7 (15.7) 9.45 1.15 to 17.83 2.32 (32) 0.014*
Subscales
 Informed (31) 46 (24) 30.7 (21) 15.3 5.46 to 25.58 3.17 (32) 0.002**
 Values clarity (32) 39.3 (25.9) 24.7 (18.6) 14.6 5.43 to 23.74 3.25 (32) 0.001**
 Support (32) 42.5 (25.7) 34 (21.4) 8.4 –2.52 to 19.45 1.57 (32) 0.063
 Uncertainty (32) 43.5 (30.4) 38.5 (22.9) 5 –6.94 to 16.84 0.85 (32) 0.201
 Effective decision (32) 37.3 (21.3) 30.9 (17.7) 6.5 –1.82 to 14.71 1.59 (32) 0.061
OPTION (32) 56.7 (18.3) 64.1 (18.5) –7.4 –14.6 to –0.28 –2.12 (32) 0.021*
DAI (33) 2.8 (4.8) 2.5 (5.1) .3 –1.11 to 1.79 0.47 (32) 0.321
*p < 0.05, **p < 0.01.
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I’ve worked with a few clients where they’ve never thought 
about opening up about medication, and they’ve had the 
belief that actually it is already decided and that they don’t 
have a choice. So the project has been really good for opening 
that up… and it sort of broadened my awareness of that 
importance of sharing, and if I hadn’t have done the project I 
don’t know whether that awareness would have been as 
prominent as it is now. (Care co-ordinator)
Some practitioners felt they had gained confidence to open 
dialogues about medication with service users, and had 
become more aware of the importance of helping service 
users in having a choice:
I think I am definitely much more open and … I don’t feel so 
scared of having those medication conversations, because 
obviously there’s always that fear, as soon as you start talking 
about medication, what’s going to happen, there’s always that 
fear of what’s the next step. And I think having done the project 
I don’t feel that fear, I feel quite comfortable, with service user, 
about what they would like, what they see would be the best for 
them and having that open discussion … and being able to 
come up with a mutual decision. (Care co-ordinator)
Yes. I think it has had impact in different ways; in my meetings 
with the patients, in my care plan reviews or medication 
reviews, I have been more focused in sharing more 
information, proposing different options, granting to the 
patient the final choice about medication. (Psychiatrist)
One psychiatrists spoke about experiencing tensions between 
his medical responsibility and the risks associated with 
reducing medication, stating ‘that’s why I am pulling my hair 
with this shared decision’. Improvements were called for in 
reducing the focus on decision-aid forms, their length and 
format. Asked about using SDM in the future, more service 
users and care co-ordinators than psychiatrists said they 
would like SDM to be an integral part of everyday practice.
Discussion
This is the first UK based study to develop and evaluate a 
training intervention to promote SDM for psychiatric med-
ication that targets both service users and practitioners. 
The generally high level of attendance at training sessions 
suggests good acceptability and engagement. This was 
confirmed by service users’ end of training feedback and 
12-month follow-up interviews. Feedback from practition-
ers at these two points was also positive, although less so 
among psychiatrists.
Quantitative measures showed encouraging changes 
among service users. They reported significantly reduced 
decisional conflict scores. Statistically significant changes 
were found on DCS sub-scales measuring feeling informed 
and clarity about personal values underpinning decisions, 
both of which may contribute to service users feeling more 
empowered and developing greater confidence in deci-
sional involvement and self-management (Stovell et al., 
2016). They indicated clear and consistent preferences for 
equal roles with psychiatrists in medication decision-mak-
ing. Their ratings of usual practice suggested that doctors 
tended to have greater decision-making roles, especially at 
baseline when a third of respondent endorsed the most 
extreme statement (‘the doctor makes the decision’) sug-
gesting little or no involvement. No changes in service 
users’ attitudes to medication were found following train-
ing. Similarly, neither service users nor practitioners 
reported changes in therapeutic relationship quality, with 
service users consistently rating relationships with pre-
scribing psychiatrists as less strong than for other practi-
tioners involved in medication management.
Most existing SDM research in mental health focuses 
on attitudes of service users and practitioners, with fewer 
studies developing decision making aids or evaluating 
their application. Compared to a decade ago, there is cur-
rently more interest in promoting SDM across stakeholder 
groups and countries. However, it is still rare to find an 
articulation of the conceptual aspects of SDM, and the dif-
ferential power relations related to it (Kaminskiy, 2015; 
Morant et al., 2015).
The connection of SDM to the strengths approach and 
the new meaning of recovery, and its role in enhancing 
therapeutic alliances is beginning to be reflected in the lit-
erature (e.g. Deegan et al., 2008). For some, SDM is a 
potential route to increasing service users’ agency and self-
management (The King’s Fund, 2011), while for others it 
is a tool to enhance treatment adherence (Nice, 2009).
Strengths and limitations
The project had a strong co-production ethos between 
researchers, service users and practitioners. This ensured 
that the agendas and concerns of both service users and 
practitioners were reflected in the design and delivery of the 
intervention (Stayley, 2014). Training content recognised 
the significance of power, and the need to acknowledge and 
challenge power inequalities among partners to the SDM 
process. Thus, assertiveness training was included for ser-
vice users, while practitioners heard direct service user 
experiences, and were exposed to being trained by both pro-
fessionals and service user trainers as equals.
Although the study had broad inclusion criteria, these 
depended on clinicians’ interpretations. Training for practi-
tioners did not provide sufficient opportunities for post train-
ing support. While the decision aids forms were subject to 
three developmental cycles, practitioners remained uncon-
vinced of their practical utility, and their uptake was low.
There are several methodological limitations of the train-
ing evaluation. Response rates at 12-month follow-up were 
poor among practitioners – due primarily to demoralisation 
resulting from service reorganisation – sample sizes were 
small, and there were no comparison group. These limit the 
strength and generalisability of the conclusions we are able 
to draw from the quantitative data. However, triangulating 
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with other data sources – training feedback and semi-struc-
tured interviews at 12-month follow-up – allows us to build 
up a rich, if tentative, picture of the strengths, weaknesses 
and impact of the training programme.
Practice implications and further 
developments
The training intervention developed in this study provided 
a largely feasible and acceptable way of enhancing SDM 
relating to psychiatric medication. This suggests it is pos-
sible to move towards more equal and collaborative dis-
cussion and decision processes between people who take 
medication and their key providers in medication manage-
ment. The project also highlights the value of including a 
wide range of mental health practitioners in SDM training. 
Compared to psychiatrists, care co-ordinators have more 
regular contact with service users, including in service 
users’ home environment. Although most of them do not 
make medication decisions, they can discuss both positive 
and negative impacts of medication, and may have greater 
awareness than psychiatrists of how it impacts on service 
users’ social functioning. Hence, this group is well-placed 
to implement components of SDM such as supporting ser-
vice users to access appropriate medication information or 
raise concerns with psychiatrists.
The frequency and nature of repeat or ‘top-up’ training 
for practitioners required to ensure sustainability of these 
principles over time to become embedded in clinical prac-
tice remains unexplored in this article. The training pro-
gramme is relatively simple, short and inexpensive, and 
could be easily adapted for implementation in many men-
tal health settings. Given that service user participants in 
this study had long-term experiences of primarily severe 
mental health problems, similar training interventions may 
be as, or more, effective for those experiencing shorter or 
milder forms of mental ill-health. There is also potential 
for broadening the scope of this training to cover non-med-
ical aspects of mental health interventions.
The less positive response to the programme of psy-
chiatrists than care-coordinators warrants further explora-
tion. Existing research highlights psychiatrists’ focus on an 
assumed lack of insight by service users of their mental 
ill-health as a key barrier to engaging in SDM (Shepherd, 
Shorthouse, & Gask, 2014). Engaging trainee psychiatrists 
early on in their career in the training of SDM, alongside 
service users, would be a useful move in this direction. The 
NHS Trust within which this work was conducted has 
taken on SDM as a preferred policy across all pathways, 
and now provides training on SDM processes to additional 
groups of practitioners (e.g. non-medical prescribers), and 
service users. The impact and organisational processes of 
embedding this type of innovation in standard mental 
health practice is worthy of research attention. The results 
indicate the value of conducting a larger research study 
that incorporates a randomised design with more repre-
sentative samples across multiple settings.
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